Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 11, 2006, Pages 1161-1166

  Therapondos, George ^a,b   Wong, Florence ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NCSB 11 C 1222   (Canada)

Author keywords

Gastric antral vascular ectasia; Hepatic hydrothorax; Hepatopulmonary syndrome; Liver transplantation; Polycystic liver disease; Portal hypertensive gastropathy; Transjugular intrahepatic portosystemic stent shunt; Veno occlusive disease

Indexed keywords

BRAIN DISEASE; CLINICAL FEATURE; ESOPHAGUS VARICES BLEEDING; HEPATIC HYDROTHORAX; HEPATOPULMONARY SYNDROME; HUMAN; HYDROTHORAX; LIVER CIRRHOSIS; LIVER DISEASE; LIVER POLYCYSTIC DISEASE; LIVER SINUSOID; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PORTAL HYPERTENSIVE GASTROPATHY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; STENT; STOMACH ANTRUM VASCULAR ECTASIA; STOMACH DISEASE; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC STENT SHUNT; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VEIN OCCLUSION;

ASCITES; HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; LIVER DISEASES; LIVER TRANSPLANTATION; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 33749845098     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000236876.60354.25     Document Type: Review

References (62)

1. Morrow CS, Kantor M, Armen RN. Hepatic hydrothorax. Ann Intern Med 1958; 49:193-203.
2. Rubinstein D, McInnes IE, Dudley FJ. Hepatic hydrothorax in the absence of clinical ascites: diagnosis and management. Gastroenterology 1985; 88:188-191.
3. Giacobbe A, Facciorusso D, Tonti P, Andriulli A, Barbano F, Frusciante V, et al. Hydrothorax complicating cirrhosis in the absence of ascites. J Clin Gastroenterol 1993; 17:271-272.
4. Singer JA, Kaplan MM, Katz RL. Cirrhotic pleural effusion in the absence of ascites. Gastroenterology 1977; 73:575-577.
5. Kirsch CM, Chui DW, Yenokida GG, Jensen WA, Bascom PB. Case report: hepatic hydrothorax without ascites. Am J Med Sci 1991; 302:103-106.
6. Johnston RF, Loo RV. Hepatic hydrothorax; studies to determine the source of the fluid and report of thirteen cases. Ann Intern Med 1964; 61:385-401.
7. Ackerman Z, Reynolds TB. Evaluation of pleural fluid in patients with cirrhosis. J Clin Gastroenterol 1997; 25:619-622.
8. Alberts WM, Salem AJ, Solomon DA, Boyce G. Hepatic hydrothorax. Cause and management. Arch Intern Med 1991; 151:2383-2388.
9. Gur C, Ilan Y, Shibolet O. Hepatic hydrothorax - pathophysiology, diagnosis and treatment: review of the literature. Liver Int 2004; 24:281-284.
10. Urbani L, Catalano G, Cioni R, Petruzzi P, Bindi L, Biancofiore G, et al. Management of massive and persistent ascites and/or hydrothorax after liver transplantation. Transplant Proc 2003; 35:1473-1475.
11. Emerson PA, Davies JH. Hydrothorax complicating ascites. Lancet 1955; 268:487-488.
12. Chen A, Ho YS, Tu YC, Tang HS, Cheng TC. Diaphragmatic defect as a cause of massive hydrothorax in cirrhosis of liver. J Clin Gastroenterol 1988; 10:663-666.
13. Datta N, Mishkin FS, Vasinrapee P, Niden AH. Radionuclide demonstration of peritoneal-pleural communication as a cause for pleural fluid. JAMA 1984; 252:210.
14. LeVeen HH, Piccone VA, Hutto RB. Management of ascites with hydrothorax. Am J Surg 1984; 148:210-213.
15. Hobbs CL, Mullen JL, Rosato EF. Peritoneovenous shunt for hydrothorax associated with ascites. Arch Surg 1982; 117:1233-1234.
16. Strauss RM, Martin LG, Kaufman SL, Boyer TD. Transjugular intrahepatic portal systemic shunt for the management of symptomatic cirrhotic hydrothorax. Am J Gastroenterol 1994; 89:1520-1522.
17. Conklin LD, Estrera AL, Weiner MA, Reardon PR, Reardon MJ. Transjugular intrahepatic portosystemic shunt for recurrent hepatic hydrothorax. Ann Thorac Surg 2000; 69:609-611.
18. Buchholz S, Kaplan V, Hauser M. Treatment of a right-sided pleural effusion in a patient with liver cirrhosis. Chest 2000; 117:248-250.
19. Andrade RJ, Martin-Palanca A, Fraile JM, Alcantara R, Carmona C, Medina MC, et al. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites. J Clin Gastroenterol 1996; 22:305-307.
20. Degawa M, Hamasaki K, Yano K, Nakao K, Kato Y, Sakamoto I, et al. Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt. J Gastroenterol 1999; 34:128-131.
21. Gordon FD, Anastopoulos HT, Crenshaw W, Gilchrist B, McEniff N, Falchuk KR, et al. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology 1997; 25:1366-1369.
22. Spencer EB, Cohen DT, Darcy MD. Safety and efficacy of transjugular intrahepatic portosystemic shunt creation for the treatment of hepatic hydrothorax. J Vasc Intervent Radiol 2002; 13:385-390.
23. Jeffries MA, Kazanjian S, Wilson M, Punch J, Fontana RJ. Transjugular intrahepatic portosystemic shunts and liver transplantation in patients with refractory hepatic hydrothorax. Liver Transplant Surg 1998; 4:416-423.
24. Krowka MJ. Clinical management of hepatopulmonary syndrome. Semin Liver Dis 1993; 13:414-422.
25. Allgaier HP, Haag K, Ochs A, Hauenstein KH, Jeserich M, Krause T, et al. Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS). J Hepatol 1995; 23:102.
26. Riegler JL, Lang KA, Johnson SP, Westerman JH. Transjugular intrahepatic portosystemic shunt improves oxygenation in hepatopulmonary syndrome. Gastroenterology 1995; 109:978-983.
27. Paramesh AS, Husain SZ, Shneider B, Guller J, Tokat I, Gondolesi GE, et al. Improvement of hepatopulmonary syndrome after transjugular intrahepatic portasystemic shunting: case report and review of literature. Pediatr Transplant 2003; 7:157-162.
28. Lasch HM, Fried MW, Zacks SL, Odell P, Johnson MW, Gerber DA, et al. Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transplant 2001; 7:147-149.
29. Chevallier P, Novelli L, Motamedi JP, Hastier P, Brunner P, Bruneton JN. Hepatopulmonary syndrome successfully treated with transjugular intrahepatic portosystemic shunt: a three-year follow-up. J Vasc Intervent Radiol 2004; 15:647-648.
30. Selim KM, Akriviadis EA, Zuckerman E, Chen D, Reynolds TB. Transjugular intrahepatic portosystemic shunt: a successful treatment for hepatopulmonary syndrome. Am J Gastroenterol 1998; 93:455-458.
31. Corley DA, Scharschmidt B, Bass N, Somberg K, Gold W. Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterology 1997; 113:728-730.
32. Nakamura T, Nakamura S, Tazawa T, Abe S, Aikawa T, Tokita K. Measurement of blood flow through portopulmonary anastomosis in portal hypertension. J Lab Clin Med 1965; 65:114-121.
33. Wong R, Rappaport W, Witte C, Hunter G, Jaffe P, Hall K, et al. Risk of nonshunt abdominal operation in the patient with cirrhosis. J Am Coll Surg 1994; 179:412-416.
34. Mansour A, Watson W, Shayani V, Pickleman J. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997; 122:730-735.
35. Schwartz SI. Biliary tract surgery and cirrhosis: a critical combination. Surgery 1981; 90:577-583.
36. Garrison RN, Cryer HM, Howard DA, Polk HC Jr. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984; 199:648-655.
37. Azoulay D, Buabse F, Damiano I, Smail A, Ichai P, Dannaoui M, et al. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg 2001; 193:46-51.
38. Gil A, Martinez-Regueira F, Hernandez-Lizoain JL, Pardo F, Olea JM, Bastarrika G, et al. The role of transjugular intrahepatic portosystemic shunt prior to abdominal tumoral surgery in cirrhotic patients with portal hypertension. Eur J Surg Oncol 2004; 30:46-52.
39. Guglielmi A, Girlanda R, Lombardo F, de Manzoni G, Frameglia M, Pelosi G, et al. TIPS allowing for an endoscopic mucosal resection of early gastric cancer in a cirrhotic patient with severe hypertensive gastropathy: report of a case. Surg Today 1999; 29:902-905.
40. Moulin G, Champsaur P, Bartoli JM, Chagnaud C, Rousseau H, Monges D. TIPS for portal decompression to allow palliative treatment of adenocarcinoma of the esophagus. Cardiovasc Intervent Radiol 1995; 18:186-188.
41. Van Ha TG, Funaki BS, Ehrhardt J, Lorenz J, Cronin D, Millis JM, et al. Transjugular intrahepatic portosystemic shunt placement in liver transplant recipients: experiences with pediatric and adult patients. Am J Roentgenol 2005; 184:920-925.
42. Lerut JP, Goffette P, Molle G, Roggen FM, Puttemans T, Brenard R, et al. Transjugular intrahepatic portosystemic shunt after adult liver transplantation: experience in eight patients. Transplantation 1999; 68:379-384.
43. Amesur NB, Zajko AB, Orons PD, Sammon JK, Casavilla FA. Transjugular intrahepatic portosystemic shunt in patients who have undergone liver transplantation. J Vasc Intervent Radiol 1999; 10:569-573.
44. Richard HM III, Cooper JM, Ahn J, Silberzweig JE, Emre SH, Mitty HA. Transjugular intrahepatic portosystemic shunts in the management of Budd-Chiari syndrome in the liver transplant patient with intractable ascites: anatomic considerations. J Vasc Intervent Radiol 1998; 9:137-140.
45. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 2002; 22:27-42.
46. Senzolo M, Cholongitas E, Patch D, Burroughs AK. TIPS for veno-occlusive disease: is the contraindication real? Hepatology 2005; 42:240-241.
47. Smith FO, Johnson MS, Scherer LR, Faught P, Breitfeld PP, Albright E, et al. Transjugular intrahepatic portosystemic shunting (TIPS) for treatment of severe hepatic veno-occlusive disease. Bone Marrow Transplant 1996; 18:643-646.
48. Fried MW, Connaghan DG, Sharma S, Martin LG, Devine S, Holland K, et al. Transjugular intrahepatic portosystemic shunt for the management of severe venoocclusive disease following bone marrow transplantation. Hepatology 1996; 24:588-591.
49. Azoulay D, Castaing D, Lemoine A, Samuel D, Majno P, Reynes M, et al. Successful treatment of severe azathioprine-induced hepatic veno-occlusive disease in a kidney-transplanted patient with transjugular intrahepatic portosystemic shunt. Clin Nephrol 1998; 50:118-122.
50. Azoulay D, Castaing D, Lemoine A, Hargreaves GM, Bismuth H. Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantation. Bone Marrow Transplant 2000; 25:987-992.
51. Zenz T, Rossle M, Bertz H, Siegerstetter V, Ochs A, Finke J. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation - role of transjugular intrahepatic portosystemic shunt (TIPS). Liver 2001; 21:31-36.
52. Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41:386-400.
53. Sanyal AJ. The use and misuse of transjugular intrahepatic portasystemic shunts. Curr Gastroenterol Rep 2000; 2:61-71.
54. Brown RS Jr, Lake JR. Transjugular intrahepatic portosystemic shunt as a form of treatment for portal hypertension: indications and contraindications. Adv Intern Med 1997; 42:485-504.
55. Shin ES, Darcy MD. Transjugular intrahepatic portosystemic shunt placement in the setting of polycystic liver disease: questioning the contraindication. J Vasc Intervent Radiol 2001; 12:1099-1102.
56. Spillane RM, Kaufman JA, Powelson J, Geller SC, Waltman AC. Successful transjugular intrahepatic portosystemic shunt creation in a patient with polycystic liver disease. Am J Roentgenol 1997; 169:1542-1544.
57. Bahramipour PF, Festa S, Biswal R, Wachsberg RH. Transjugular intrahepatic portosystemic shunt for the treatment of intractable ascites in a patient with polycystic liver disease. Cardiovasc Intervent Radiol 2000; 23:232-234.
58. Kamath PS, Lacerda M, Ahlquist DA, McKusick MA, Andrews JC, Nagorney DA. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 2000; 118:905-911.
59. Urata J, Yamashita Y, Tsuchigame T, Hatanaka Y, Matsukawa T, Sumi S, et al. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol 1998; 13:1061-1067.
60. Spahr L, Villeneuve JP, Dufresne MP, Tasse D, Bui B, Willems B, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut 1999; 44:739-742.
61. McCormick PA, Ooi H, Crosbie O. Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut 1998; 42:750-752.
62. Mezawa S, Homma H, Ohta H, Masuko E, Doi T, Miyanishi K, et al. Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 2001; 96:1155-1159.